Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1206.00

7.05 (0.59%)

< Home < Back

Dr. Reddy’s Laboratories informs about press release

Date: 01-08-2026

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release, ‘Dr. Reddy's Laboratories Receives U.S. FDA Approval for Rituximab Biosimilar’.

The above information is a part of company’s filings submitted to BSE.